Acute Porphyria Drug Database

Monograph

N07AA30 - Ambenonium
Propably not porphyrinogenic
PNP

Rationale
Probably non-oxidative metabolism. No data pointing to CYP-interaction.
Chemical description
Cholinesterase inhibitor of long duration (5-8 hours) used in myasthenia gravis. No data pointing to CYP-interaction.

Similar drugs
Explore alternative drugs in similar therapeutic classes N07A / N07AA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Norway
Mytelase
Poland
Mytelase
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙